FDA Moves to Ban Gas Station and Kratom Products with Opioid-Like Effects
TL;DR Summary
The FDA is recommending scheduling 7-hydroxymitragynine (7-OH), a potent opioid byproduct of kratom, under the Controlled Substances Act to prevent abuse and protect public health, especially among youth, amid concerns over its increasing availability and potential for addiction.
- FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers HHS.gov
- FDA asks Justice Department to classify gas station products with opioid-like effects as illicit substances NBC News
- Products with opioid-like effects sold at gas stations may be banned as illicit substances USA Today
- US health officials crack down on kratom-related products after complaints from supplement industry AP News
- FDA pushes for federal oversight of potent kratom compound Axios
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
3 min
vs 3 min read
Condensed
94%
591 → 38 words
Want the full story? Read the original article
Read on HHS.gov